BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16330021)

  • 1. Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats.
    Li B; Suemaru K; Cui R; Kitamura Y; Gomita Y; Araki H
    Eur J Pharmacol; 2006 Jan; 529(1-3):114-21. PubMed ID: 16330021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test.
    Li B; Suemaru K; Cui R; Araki H
    Life Sci; 2007 Mar; 80(16):1539-43. PubMed ID: 17306836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Barbosa LM; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):140-4. PubMed ID: 17884272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).
    Consoli D; Fedotova J; Micale V; Sapronov NS; Drago F
    Eur J Pharmacol; 2005 Sep; 520(1-3):100-7. PubMed ID: 16150440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal.
    Filip M; Faron-Górecka A; Kuśmider M; Gołda A; Frankowska M; Dziedzicka-Wasylewska M
    Brain Res; 2006 Feb; 1071(1):218-25. PubMed ID: 16423334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T; Tokumura M; Abe K
    Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
    Larsen MH; Mikkelsen JD; Hay-Schmidt A; Sandi C
    J Psychiatr Res; 2010 Oct; 44(13):808-16. PubMed ID: 20172535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.
    Fortunato JJ; Réus GZ; Kirsch TR; Stringari RB; Stertz L; Kapczinski F; Pinto JP; Hallak JE; Zuardi AW; Crippa JA; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1425-30. PubMed ID: 19632287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
    Réus GZ; Stringari RB; Kirsch TR; Fries GR; Kapczinski F; Roesler R; Quevedo J
    Brain Res Bull; 2010 Apr; 81(6):585-9. PubMed ID: 19954760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrophobic dipeptide Leu-Ile inhibits immobility induced by repeated forced swimming via the induction of BDNF.
    Furukawa-Hibi Y; Nitta A; Ikeda T; Morishita K; Liu W; Ibi D; Alkam T; Nabeshima T; Yamada K
    Behav Brain Res; 2011 Jul; 220(2):271-80. PubMed ID: 21315766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice.
    Shieh CH; Hong CJ; Huang YH; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1590-4. PubMed ID: 18582526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF].
    Li B; Suemaru K; Kitamura Y; Cui R; Gomita Y; Araki H
    Yakugaku Zasshi; 2007 Apr; 127(4):735-42. PubMed ID: 17409705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral changes after maternal separation are reversed by chronic constant light treatment.
    Dimatelis JJ; Stein DJ; Russell VA
    Brain Res; 2012 Oct; 1480():61-71. PubMed ID: 22975437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
    Siuciak JA; Lewis DR; Wiegand SJ; Lindsay RM
    Pharmacol Biochem Behav; 1997 Jan; 56(1):131-7. PubMed ID: 8981620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
    Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
    Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.
    Huang Z; Zhong XM; Li ZY; Feng CR; Pan AJ; Mao QQ
    Neurosci Lett; 2011 Apr; 493(3):145-8. PubMed ID: 21334417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.
    Tamburella A; Micale V; Leggio GM; Drago F
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):704-13. PubMed ID: 20537869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.